<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03884647</url>
  </required_header>
  <id_info>
    <org_study_id>0038-19</org_study_id>
    <nct_id>NCT03884647</nct_id>
  </id_info>
  <brief_title>DELPhI Software for the Analysis of TMS-EEG Data of Brain Functionality - a Healthy Population Norm Collection Study</brief_title>
  <official_title>DELPhI Software for the Analysis of TMS-EEG Data of Brain Functionality - a Healthy Population Norm Collection Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>QuantalX Neuroscience</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>QuantalX Neuroscience</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The DELPhi system is a software device that is used for the noninvasive evaluation of brain
      plasticity and connectivity. The DELPhi software uses EEG and TMS devices as accessories.
      Standard electro-physiological acquisition is performed using TMS to evoke regional neuronal
      potentials measured as EEG data. TMS-EEG data is analyzed with regards to conventional, well
      established characteristics of neuronal network plasticity and connectivity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation method that allows
      to study human cortical function in vivo. Using TMS for examining human cortical
      functionality is enhanced by combining TMS with simultaneous registration of
      electroencephalograph (EEG). EEG provides an opportunity to directly measure the cerebral
      response to TMS. Measuring the cortical TMS Evoked potential (TEP), is used to assess
      cerebral reactivity across wide areas of neocortex.

      By evaluating the propagation of evoked activity in different behavioral states and in
      different tasks, TMS-EEG has been used to causally probe the dynamic effective connectivity
      of human brain networks.

      In this study the sponsor is intended to establish Norms for the DELPhI test by measuring
      healthy subjects at the ages of 25-45.At this ages, the human brain has finished its normal
      processes of development and not yet manifest degenerative and hemo-dynamic related
      deterioration of brain structure. The sponsor will recruit neurologically and psychiatric
      healthy subjects' cohort to describe the normal distribution of such population. Some of the
      patients agreeing to perform a second test will serve for a reliability test.

      Main objectives:

        1. Definition of DELPhi's healthy population average TEP response in normal, healthy
           population between the ages 25-45 +/- STD.

        2. Defining DELPhI's test-retest reliability by quantifying correlation coefficient between
           two tests in young healthy population.

      Exploratory objectives:

        1. Evaluating the sham stimulation effect.

        2. Assessing con founders effecting results.

      Subjects will perform a medical and neurological evaluation, demographic, State-Trait Anxiety
      Inventory (STAI) and Difficulties in Emotion Regulation Scale (DERS) questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Establishing DELPhI's norms of young healthy population.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>mean, STD, standard error (SEM), coefficient of variation (CV%), minimum, median, maximum and 95% confidence interval for every DELPhI parameter based on the young healthy population normal distribution.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Examining DELPhI's reliability by defining Intra-Class Correlation (ICC) coefficients</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Examining DELPhI's reliability by defining Intra-Class Correlation (ICC) coefficients between two tests performed 1-30 days apart at each of DELPhI's parameters.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DELPhI (software as a medical device)</intervention_name>
    <description>DELPhI software is acquiring and analyzing the TMS evoked response recorded with the EEG.</description>
    <other_name>Transcranial magnetic stimulation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        N= 200 subjects recruited by advertisements in the clinics and campuses and social media,
        in the format approved by IRB.

        100 subjects will be recruited for the initial part of the study and an additional 100
        subjects for the extension study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female at the ages of 25-45.

          2. Subjects that declare themselves as healthy.

          3. Willing to cooperate with all study procedures.

        Exclusion Criteria:

          1. Subjects that declare any neurological or psychiatric condition or illness in their
             medical history.

          2. Prior known epileptic episode.

          3. Subjects that receives brain directed medical treatment.

          4. Subjects that report drug abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Iftach Dolev, PhD</last_name>
    <phone>+972-44659491</phone>
    <email>doleviftach@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Noa Zifman, MSc</last_name>
    <phone>+972-37553213</phone>
    <email>noazif@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Asaf-Harophe</name>
      <address>
        <city>Rishon LeZion</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 19, 2019</study_first_submitted>
  <study_first_submitted_qc>March 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2019</study_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

